Tango Therapeutics, Inc.
TNGX
$17.91
$0.613.53%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -343.95% | 140.88% | 2.57% | -5.86% | -29.15% |
| Total Depreciation and Amortization | -13.69% | -11.20% | 0.48% | 0.32% | -0.32% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -12.59% | 2.51% | -9.35% | 0.30% | 8.90% |
| Change in Net Operating Assets | 104.41% | -955.62% | 48.52% | -40.14% | 39.32% |
| Cash from Operations | 3.99% | 15.24% | 12.42% | -13.78% | -9.75% |
| Capital Expenditure | -47.02% | 75.80% | -1,123.53% | 58.87% | -7.83% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -384.49% | 173.69% | -43.22% | -41.27% | 59.66% |
| Cash from Investing | -385.86% | 182.97% | -45.16% | -41.23% | 59.84% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 8,534.87% | 337.35% | 28,950.00% | -99.79% | -59.66% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 8,533.45% | 337.35% | 28,950.00% | -99.79% | -59.66% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 182.92% | 199.51% | -72.64% | -167.75% | 935.52% |